ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $300,000 | -73.2% | 9,542 | -43.9% | 0.03% | +106.2% |
| Q4 2017 | $1,119,000 | -81.9% | 17,000 | -86.2% | 0.02% | -77.5% |
| Q3 2017 | $6,194,000 | +65.7% | 123,600 | +53.0% | 0.07% | +26.8% |
| Q2 2017 | $3,739,000 | -36.6% | 80,800 | -51.6% | 0.06% | -37.8% |
| Q1 2017 | $5,893,000 | +554.8% | 166,900 | +132.1% | 0.09% | +291.3% |
| Q4 2016 | $900,000 | +710.8% | 71,900 | +536.3% | 0.02% | +360.0% |
| Q2 2016 | $111,000 | -72.5% | 11,300 | -33.9% | 0.01% | -83.3% |
| Q3 2015 | $403,000 | -79.7% | 17,100 | -20.5% | 0.03% | -84.3% |
| Q1 2015 | $1,990,000 | – | 21,500 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
| Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
| WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
| EMC Capital Management | 27,566 | $246,000 | 0.14% |
| PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
| Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
| Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |